[1]
Samarghandian, S. et al. 2013. Safranal Treatment Improves Hyperglycemia, Hyperlipidemia and Oxidative Stress in Streptozotocin-Induced Diabetic Rats. Journal of Pharmacy & Pharmaceutical Sciences. 16, 2 (Aug. 2013), 352–362. DOI:https://doi.org/10.18433/J3ZS3Q.